Lv3
230 积分 2022-10-25 加入
Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension
1小时前
已完结
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF
1小时前
已完结
Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
1小时前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
6天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
8天前
已完结
Advances in the study and treatment of genetic cardiomyopathies
9天前
已完结
Perindopril 3.5 mg/amlodipine 2.5 mg versus renin–angiotensin system inhibitor monotherapy as first-line treatment in hypertension
14天前
已完结
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study
14天前
已完结
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study
15天前
已完结
Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension
15天前
已完结
皖公网安备34019202002308
